Logo
C

Candel Therapeutics

71 employees

Candel Therapeutics develops cancer immunotherapies designed to improve the lives of cancer patients and their families.

Basic info

Industry

biotechnology research

Sectors

Immuno-oncology
Biotechnology
Prostate Cancer
Therapeutics
Viral Immunotherapy
Health Diagnostics
Genetics
Medical
Health Care
Oncology
Brain Cancer

Date founded

1999

Funding rounds raised

Total raised

$29M

from 4 investors over 4 rounds

C

Candel Therapeutics raised $23M on April 1, 2019

Investors: Northpond Ventures and Sands Capital Management

C

Candel Therapeutics raised $29M on January 4, 2019

Investors: PBM Capital Group

C

Candel Therapeutics raised $500K on May 25, 2011

Investors: Massachusetts Life Sciences Center

FAQ